The hydrokinetic fiber dressings market is anticipated to reach US$ 251.1 million by 2032 from an estimated US$ 164.2 million in 2022. During the forecast period (2022 to 2032), the market is anticipated to grow at a CAGR of 3.9%, compared to 3.6% during the historical period (2017 to 2021).
The market is fueled by high demand for inexpensive and non-invasive dressing options, favorable reimbursement policies for chronic wound care products, the rising prevalence of chronic wounds worldwide, and the accessibility of new technologies that help lessen pain and enhance the quality of life. Additionally, the prevalence of diabetes mellitus type 2 patients have been rising globally, which has driven the growth rate by increasing the frequency of diabetic foot ulcers or neuropathic foot ulcerations.
The hydration response technique (HRT) supports dressings made of hydrokinetic fiber. Hydrokinetic fiber is a moisture-retentive dressing fiber that efficiently eliminates germs from the wound bed, reduces odor, has a very low risk of skin irritation and inflammation, and is incredibly pleasant to wear. The matrix that hydrokinetic fibers normally create is unique in its mixture of constituents, including their mass, percentages, and density.
Sodium polyacrylate and hydrophilic cellulose particles often referred to as cellulose fibers, are used in a complex mechanical process to create hydrokinetic fibers. Additionally, lignocellulosic materials must be bound to gel-forming polymers for hydrokinetic fibers to produce an absorbent dressing pad.
| Report Attribute | Details |
|---|---|
| Hydrokinetic Fiber Dressings Market Historical Growth Rate (2017 to 2021) | 3.6% |
| Hydrokinetic Fiber Dressings Market Value (2022) | US$ 164.2 million |
| Hydrokinetic Fiber Dressings Market Anticipated Forecast Value (2032) | US$ 251.1 million |
| Hydrokinetic Fiber Dressings Market Projected Growth Rate (2022 to 2032) | 3.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The older population and the expanding demands in the biotechnology industry are the primary drivers of the market for hydrokinetic fiber dressings. The market's expansion is also fueled by the healthcare industry's evolving trends, tightening regulations, and growing emphasis on cost-cutting measures, all of which have raised the rate at which various healthcare institutions are adopting hydrokinetic fiber dressings.
The incidence of chronic diseases has increased along with the number of treatments done. Hydrokinetic fiber dressings are therefore being utilized more frequently to stop postoperative complications. Most surgical wounds created by cancer surgery are large and deep, producing exudates that must be regularly controlled. Large wounds could be managed with these dressings, greatly reducing the danger of infection. As a result, the rising incidence of chronic illnesses would fuel demand for hydrokinetic fiber dressings and propel market growth.
Other reasons driving the market's expansion include the development of the healthcare infrastructure, a greater emphasis on eradicating diseases brought on by wounds, and the creation of contaminant-free environments. Lastly, in wound care, standards are being raised to ensure that wounds receive excellent care, which will accelerate market expansion.
Prominent factors that might limit the growth of the global market include the high cost of active wound care therapies as well as the high cost of complex wound dressing technology items and equipment. Although these dressing treatments for wounds and burns are quite efficient, they are also very expensive. Since not everyone can afford these costs, hydrokinetic fiber dressings' expansion on the worldwide market is being restrained.
The greatest challenge in the global industry is also the stress of competitive pricing. The price of the top rivals is very competitive, which disrupts the world market. The total CAGR is anticipated to decrease if the same scenario holds true throughout the projection period.
Principal Consultant
The hydrokinetic fiber dressings market was led by the segment of acute wounds based on wound type. It is anticipated that the segment would grow quickly throughout the forecast period. Burns and surgical and traumatic wounds are examples of acute wounds. Acute wounds recover within a few weeks of the initial injury. Several traumas, such as surgical incisions and dog bites, can result in acute wounds. The percentage of people with at least one wound who are taken to hospitals is around 30%.
One in five patients admitted to the hospital had at least one skin tear. Furthermore, at least one wound was present in around half of all hospital deaths. Such wounds can be healed.
The hospitals and specialty wound care clinics segment dominates the market as far as the end-user part is concerned. In hospitals, hydrokinetic fiber dressings are used to treat both acute and chronic wounds. They aid in the drainage of the wound's fluid and encourage healing. The coverings also guard the wound against infection. Hydrokinetic fiber dressings come in various sizes and forms to meet the demands of various patients. They don't need any particular training and are simple to operate. Hydrokinetic fiber dressings are used in specialty wound care clinics to aid in healing acute and chronic wounds. They work well to drain extra fluid from the wound and encourage cell development. This hastens the healing process and enhances the patient's final results.
North America is currently leading the hydrokinetic fiber dressing industry. According to Future Market Insights Analysts, North America's hydrokinetic fiber dressings market is likely to reach a global market size of 39.9% by 2022. The rising use of hydrokinetic fiber dressings, adequate skilled individuals and well-developed healthcare infrastructure, and the rise in the number of biotechnology and pharmaceutical firms operating in this region all contribute to the market's expansion.
The region is anticipated to grow at a notable rate of 3.5% throughout the predicted period. The regional market for hydrokinetic fiber dressing is anticipated to grow due to rising traffic accidents, sports injuries, and multiple important businesses in the region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
With consistent expansion, Europe will represent around 30.0% of the worldwide market share by 2022. In Europe, there are several different types of wound care clinics. In Specialty Wound Care Clinics, hydrokinetic fiber dressings are utilized to speed the recovery of both acute wounds and chronic burns. They aid in eliminating extra fluid from wounds and encourage cell growth. This can speed up healing and improve the patient's overall prognosis.
The growth in Europe is anticipated to increase due to the increase in patient visits to these clinics during the forecast period. The large market share of hydrokinetic fiber dressings held by Western Europe is the result of factors such as an aging population, an increase in the prevalence of chronic and acute wounds, rising healthcare costs with higher disposable income, and the existence of significant market players.
Throughout the forecast period, Asia Pacific is anticipated to have the quickest growth in the hydrokinetic fiber dressings market. Developing nations like Japan, China, and India are anticipated to boost market expansion in the area. The rapidly growing medical tourism industry in these nations is also a result of the rising need for hydrokinetic fiber dressings in the area.
India had 58,300 medical tourists on medical visas from 2019 to 2020, according to the Directorate-General of Commercial Intelligence and Statistics of India's report on Export Health Services. Throughout the forecast period, such events are anticipated to strengthen the Asia Pacific market.
In response to the expansion of the healthcare infrastructure, the hydrokinetic fiber dressing market has become increasingly fragmented and competitive. As a result, startups are attempting to stand out from established market competitors to attract clients through technological inventions.
Example:
The major players in the hydrokinetic fiber dressings Market are currently more active than ever in developing strategies like targeted advertising, CSR programs, and other things to grow their worldwide prominence. Across the board, there has been a significant trend that these organizations are now trying to manage certain business-related activities in a nation with favorable laws. Consequently, these businesses can reduce expenses while continuing to hire business experts at each crucial stage of their particular businesses. Governments in developing countries such as China, India, Taiwan, and Indonesia are adopting strategies to entice international investors to their respective manufacturing sectors by lowering trade taxes and customs to increase job possibilities.
Example:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 3.9% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global hydrokinetic fiber dressings market is expected to grow at a 3.9% CAGR and secure US$ 251.1 Million by 2032.
North America is expected to be the fastest-growing market for Hydrokinetic fiber dressings during the forecast period and is expected to acquire a market share of 39.9% in 2022.
Sorbion GmbH & Co. KG, Alliqua, Inc.., Acelity L.P. Inc., Acell, Inc., Smith & Nephew, Plc, Organogenesis, Inc., Angelini Pharma, Inc, BSN Medical, Inc., ConvaTec, Inc., Derma Sciences, DeRoyal Industries, Ethicon, Inc, Medline Industries, Inc, Southwest Technologies are some of the known players in the Hydrokinetic fiber dressings market.
1. Executive Summary | Hydrokinetic Fibre Dressings Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Wound Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Wound Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Wound Type, 2022 to 2032 5.3.1. Acute wounds 5.3.2. Burns 5.3.3. Surgical & traumatic wounds 5.3.4. Chronic wounds 5.3.5. Venous leg ulcers 5.3.6. Pressure ulcers 5.3.7. Diabetic foot ulcers 5.3.8. Other chronic wounds 5.4. Y-o-Y Growth Trend Analysis By Wound Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Wound Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032 6.3.1. Hospitals and specialty wound care clinics 6.3.2. Inpatient 6.3.3. Outpatient 6.3.4. Long-term care facilities 6.3.5. Home healthcare 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. United States of America 8.2.1.2. Canada 8.2.2. By Wound Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Wound Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Wound Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Wound Type 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Wound Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Wound Type 10.3.3. By End User 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Malaysia 11.2.1.5. Singapore 11.2.1.6. Australia 11.2.1.7. Rest of Asia Pacific 11.2.2. By Wound Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Wound Type 11.3.3. By End User 11.4. Key Takeaways 12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of Middle East and Africa 12.2.2. By Wound Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Wound Type 12.3.3. By End User 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. United Kingdom 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Wound Type 13.1.2.2. By End User 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Wound Type 13.2.2.2. By End User 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Wound Type 13.3.2.2. By End User 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Wound Type 13.4.2.2. By End User 13.5. Rest of Latin America 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Wound Type 13.5.2.2. By End User 13.6. Germany 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Wound Type 13.6.2.2. By End User 13.7. United Kingdom 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Wound Type 13.7.2.2. By End User 13.8. France 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Wound Type 13.8.2.2. By End User 13.9. Spain 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Wound Type 13.9.2.2. By End User 13.10. Italy 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Wound Type 13.10.2.2. By End User 13.11. Rest of Europe 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Wound Type 13.11.2.2. By End User 13.12. China 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Wound Type 13.12.2.2. By End User 13.13. Japan 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Wound Type 13.13.2.2. By End User 13.14. South Korea 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Wound Type 13.14.2.2. By End User 13.15. Malaysia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Wound Type 13.15.2.2. By End User 13.16. Singapore 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2021 13.16.2.1. By Wound Type 13.16.2.2. By End User 13.17. Australia 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2021 13.17.2.1. By Wound Type 13.17.2.2. By End User 13.18. Rest of Asia Pacific 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2021 13.18.2.1. By Wound Type 13.18.2.2. By End User 13.19. GCC Countries 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2021 13.19.2.1. By Wound Type 13.19.2.2. By End User 13.20. South Africa 13.20.1. Pricing Analysis 13.20.2. Market Share Analysis, 2021 13.20.2.1. By Wound Type 13.20.2.2. By End User 13.21. Israel 13.21.1. Pricing Analysis 13.21.2. Market Share Analysis, 2021 13.21.2.1. By Wound Type 13.21.2.2. By End User 13.22. Rest of the Middle East and Africa 13.22.1. Pricing Analysis 13.22.2. Market Share Analysis, 2021 13.22.2.1. By Wound Type 13.22.2.2. By End User 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Wound Type 14.3.3. By End User 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Essity 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. Alliqua, Inc 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. Acelity L.P. Inc 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Acell, Inc 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. Smith & Nephew, Plc 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. Organogenesis, Inc 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. Angelini Pharma, Inc 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. BSN Medical, Inc 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.9. ConvaTec, Inc. 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.10. Derma Sciences 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 15.1.11. DeRoyal Industries 15.1.11.1. Overview 15.1.11.2. Product Portfolio 15.1.11.3. Profitability by Market Segments 15.1.11.4. Sales Footprint 15.1.11.5. Strategy Overview 15.1.11.5.1. Marketing Strategy 15.1.12. Ethicon, Inc. 15.1.12.1. Overview 15.1.12.2. Product Portfolio 15.1.12.3. Profitability by Market Segments 15.1.12.4. Sales Footprint 15.1.12.5. Strategy Overview 15.1.12.5.1. Marketing Strategy 15.1.13. Medline Industries, Inc 15.1.13.1. Overview 15.1.13.2. Product Portfolio 15.1.13.3. Profitability by Market Segments 15.1.13.4. Sales Footprint 15.1.13.5. Strategy Overview 15.1.13.5.1. Marketing Strategy 15.1.14. Southwest Technologies 15.1.14.1. Overview 15.1.14.2. Product Portfolio 15.1.14.3. Profitability by Market Segments 15.1.14.4. Sales Footprint 15.1.14.5. Strategy Overview 15.1.14.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Healthcare Insights
View Reports
Hydrokinetic Fibre Dressings Market
